In this episode of From Lab to Launch, we’re excited to welcome Joe Luminiello, CEO of RCG Intel, a firm dedicated to uncovering the insights that drive smarter strategy in the pharmaceutical and biotech industries.
Joe brings a sharp perspective on AI adoption, talent development, and long-term organizational strategy. As companies rush to automate entry-level roles, he highlights an often-overlooked risk: removing the very talent pipeline that future leadership depends on. Joe explores why successful organizations must balance AI integration with cultivating the next generation of leaders, treating AI as a powerful tool—not a replacement for human growth and succession planning.
Joe joined Meg for a thoughtful conversation about strategic succession planning in the AI era, how organizations can avoid short-sighted automation decisions, and how RCG Intel approaches research like investigative journalism—peeling back layers of information to deliver the context and insights leaders need to see the bigger picture in an increasingly complex healthcare landscape.
Podden och tillhörande omslagsbild på den här sidan tillhör
Qualio. Innehållet i podden är skapat av Qualio och inte av,
eller tillsammans med, Poddtoppen.
